| Home | | Conditions | | Products | | Clinical Evidence | | Education & Training | | For Patients | | Customer Support |
KCI therapies help patients heal …restoring them to active, productive lives.
| News | Medical Professionals | Patient Stories | ||
|---|---|---|---|---|
|
KCI Shareholders to receive $68.50 per share in cash. |
The V.A.C.Via™ System streamlines access to Negative Pressure Wound Therapy into a purchased single-use, portable, discreet device that provides 7 days of V.A.C.® Therapy. |
See how V.A.C.® Therapy helped a soldier win the fight against a terrible wound. |
||
|
KCI's V.A.C.Via™ Therapy System to be Listed on U.K. Drug Tariff |
The first powered negative pressure product designed specifically for management of incisions at risk of postoperative complications. |
|||
With more than 715 peer-reviewed articles, the clinical and economic benefits of V.A.C.(Vacuum Assisted Closure) Therapy are widely known.
KCI is committed to advancing healing technology that positively impacts the lives of patients, their families, caregivers and providers alike.
Product Labelling | Investor Relations | News & Media | Careers |